CHRISTEN BROOKS: Open Payments
NPI 1225497134 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$251 in 11 payments from 7 companies in 2025. Trend: 2023 $508 · 2024 $251 · 2025 $251
Food & beverage: $251
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 3 | $64 |
| Janssen Biotech, Inc. | 2 | $60 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| TerSera Therapeutics LLC | 1 | $27 |
| PFIZER INC. | 1 | $15 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: ERLEADA, XIFAXAN, ELIQUIS, Polivy, NINLARO, Zoladex, Venclexta, Tecentriq.
Industry payments across GA — which companies pay providers there.
